title: Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment?
authors.forename: A
authors.initials: A
authors.lastname: Jütte
authors.forename: A
authors.initials: A
authors.lastname: Schwenk
authors.forename: C
authors.initials: C
authors.lastname: Franzen
authors.forename: K
authors.initials: K
authors.lastname: Römer
authors.forename: F
authors.initials: F
authors.lastname: Diet
authors.forename: V
authors.initials: V
authors.lastname: Diehl
authors.forename: G
authors.initials: G
authors.lastname: Fätkenheuer
authors.forename: B
authors.initials: B
authors.lastname: Salzberger
mesh_terms: D000328:Adult; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced*
chemical_list: D017320:HIV Protease Inhibitors